National Patient Safety Alert: Potential for inappropriate dosing of insulin when switching insulin degludec (Tresiba®) products
National Patient Safety Alert: Potential for inappropriate dosing of insulin when switching insulin degludec (Tresiba®) products National Patient Safety Alert Reference Number: NatPSA/2023/016/DHSC Date issued: 8th December 2023 Brief description of the problem A Medicine Supply Notification issued on 24 May 2023, detailed a shortage of Tresiba® (insulin degludec) FlexTouch® 100units/ml solution for injection 3ml [...]
The post National Patient Safety Alert: Potential for inappropriate dosing of insulin when switching insulin degludec (Tresiba®) products appeared first on Community Pharmacy England.
Recent Comments